Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Oct 13, 2021. (Total: 3527 publications since 2011)
   dataset
Filtered By:
Records 1-8 (of 8 Records)
Query Trace: all>>Mark A Pallansch[CDC Author]
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Dominika A Kalkowska, Mark A Pallansch, Steven G F Wassilak, Stephen L Cochi, and Kimberly M Thompson
Vaccine 2021 5
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda S Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, and Kimberly M Thompson
Risk analysis : an official publication of the Society for Risk Analysis 2020 Nov
Updated Characterization of Post-OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart.
Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, Stephanie D Kovacs, Steven G F Wassilak, and Kimberly M Thompson
Risk analysis : an official publication of the Society for Risk Analysis 2020 Jul
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.
Asghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, Steve G Wassilak, Mark A Pallansch, Samantha Kluglein, Jessica Quinn, Roland W Sutter, Xiaochuan Wang, Ozden Sanal, Tatiana Latysheva, Aydan Ikinciogullari, Ewa Bernatowska, Irina A Tuzankina, Beatriz T Costa-Carvalho, Jose Luis Franco, Raz Somech, Elif Karakoc-Aydiner, Surjit Singh, Liliana Bezrodnik, Francisco J Espinosa-Rosales, Anna Shcherbina, Yu-Lung Lau, Shigeaki Nonoyama, Fred Modell, Vicki Modell, , Mohamed-Ridha Barbouche, and Mark A McKinlay
Frontiers in immunology 2017 685
The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.
Tori L Cowger, Cara C Burns, Salmaan Sharif, Howard E Gary, Jane Iber, Elizabeth Henderson, Farzana Malik, Syed Sohail Zahoor Zaidi, Shahzad Shaukat, Lubna Rehman, Mark A Pallansch, and Walter A Orenstein
PloS one 2017 (7) e0180608
Development of an efficient entire-capsid-coding-region amplification method for direct detection of poliovirus from stool extracts.
Minetaro Arita, David R Kilpatrick, Tomofumi Nakamura, Cara C Burns, David Bukbuk, Soji B Oderinde, M Steven Oberste, Olen M Kew, Mark A Pallansch, and Hiroyuki Shimizu
J. Clin. Microbiol. 2015 Jan 53(1) 73-8
Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance.
Gendro Wahjuhono, Revolusiana, Dyah Widhiastuti, Julitasari Sundoro, Tri Mardani, Woro Umi Ratih, Retno Sutomo, Ida Safitri, Ondri Dwi Sampurno, Bardan Rana, Merja Roivainen, Anna-Lea Kahn, Ondrej Mach, Mark A Pallansch, and Roland W Sutter
The Journal of infectious diseases 2014 Nov S347-52
Detection of vaccine-derived polioviruses in Mexico using environmental surveillance.
Alejandra Esteves-Jaramillo, Concepción F Estívariz, Silvia Peñaranda, Vesta L Richardson, Jesús Reyna, Diana L Coronel, Veronica Carrión, Jose M Landaverde, Steven G F Wassilak, Elda E Pérez-Sánchez, Irma López-Martínez, Cara C Burns, and Mark A Pallansch
J. Infect. Dis. 2014 Nov 1. 210 Suppl 1S315-23
TOP